Gilead's top late-stage drug selonsertib, for patients with compensated cirrhosis due to nonalcoholic steatohepatitis (NASH), has failed a phase 3 trial. The drug, an apoptosis signal-regulating ...

Read reviews by dealership customers, get a map and directions, contact the dealer, view inventory, hours of operation, and dealership photos and video. Learn about Nash Chevrolet in Lawrenceville ...

Gilead and Novo Nordisk have announced that a study testing various drug combinations for the fatty liver disease known as NASH has checked out in a mid-stage proof-of-concept study.